Loading....
The Reagan-Udall Foundation for the FDA, in collaboration with the U.S. Food and Drug Administration (FDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), is holding a two-day virtual public meeting entitled “Considerations for Buprenorphine Initiation and Maintenance Care.”
This virtual public meeting will explore real-world experiences and scientific evidence for buprenorphine initiation strategies as well as medication dosing and management during continued treatment across different care settings. To support efforts to develop products and approaches to treat OUD, presentations and discussions will include people who use drugs, their families and community, harm reduction programs, health professionals from inpatient and outpatient settings, academic researchers, and federal partners
Opioid use disorder (OUD) is a major public health issue. Buprenorphine is a safe and effective prescription medication used for treatment of OUD. One challenge in accessing treatment for OUD with buprenorphine is that initiation of buprenorphine takes careful planning: patients must already be experiencing mild to moderate withdrawal symptoms or risk precipitated withdrawal. An increase in fentanyl in the illicit drug supply has further complicated buprenorphine initiation and maintenance. Current evidence underlying the best strategy for initiating and maintaining buprenorphine care is mixed. A better understanding of the landscape of available tools and strategies for best practices in OUD care with buprenorphine is needed to advance the development of and access to evidence-based treatment for OUD, a priority under the FDA Overdose Prevention Framework and the U.S. Department of Health and Human Services (HHS) Overdose Prevention Strategy.
Considerations for Buprenorphine Initiation and Maintenance Care
Zoom Webinar
May 10- May 11
Considerations for Buprenorphine Initiation and Maintenance Care
May 10- May 11
Zoom Webinar
Checkout
Take Action
Sorry, we're not targeting any representatives in your district. But, you can still help!
Edit this message to tell users that can't take action (because of their location) how to contribute. For example, consider adding a link to a petition or donation page that you have created, or add social sharing options so that these supporters can help get the word out on social media.
Considerations for Buprenorphine Initiation and Maintenance Care
May 10- May 11
Zoom Webinar
Thank You!
You're all set. A copy of your receipt will be emailed to you.
Zoom webinar details
When: May 10, 2023, 1 PM Eastern Time (US and Canada)
May 11, 2023 1 PM Eastern Time (US and Canada)
Please click the link below to join the webinar:
https://us06web.zoom.us/s/87434107486
Or One tap mobile :
| US: +13092053325,,87434107486# or +13126266799,,87434107486# |
Or Telephone:
| For higher quality, dial a number based on your current location. | |
| Dial: | |
| Webinar ID: | 874 3410 7486 |
| Passcode: | 125942 |
,
Follow Us